Nov 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2017 Sep 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 19 mln 22 mln 186 mln
(-11.8 pct) (-36.8 pct) (+736.8 pct)
Operating loss 813 mln loss 1.05 loss 1.26
Recurring loss 817 mln loss 1.02 loss 1.24
Net loss 712 mln loss 996 mln loss 1.21
EPS loss 83.65 yen loss 125.22 yen loss 141.70 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T
((Tokyo Headline News Desk +813 6441 1812))